WASHINGTON — A California biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China, underscoring the possible tradeoffs between health innovation and a largely bipartisan push in Congress to counter Beijing’s global influence. The competition between the world’s superpowers … Read more
LONDON — A High Court judge on Monday upheld the British government’s emergency ban on puberty blockers, saying a study that found “very substantial risks and very narrow benefits” of the treatment supported the restriction as potentially being harmful. Justice Beverley Lang said a review commissioned by England’s National Health Service concluded that gender care … Read more
Promising trials of a new antibiotic drug trademarked as Zaynich – meant to act against all major superbugs – has triggered a sharp run-up in the Wockhardt stock. It has jumped nearly 75% in less than a month as the Street steadily factored in the immense opportunity that could open for the drug once launched … Read more
A GP of 30 years has hailed the trial of an innovative cancer vaccine as a “significant breakthrough” that will “herald a new age” of cancer treatment, as it is set to be given to thousands of NHS patients. The cutting edge treatment has been developed for cancer patients to destroy any lingering tumour cells … Read more
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost significant weight but had trouble tolerating the drug in a mid-stage clinical study. The drugmaker observed high rates of adverse side effects, which were mostly mild and gastrointestinal, among patients. A … Read more
